Risk Assessment in PAH
Case Study: 54-Year-Old Woman Referred for Consultation Because of Abnormal Echo
Exam and Findings
Invasive and Noninvasive Metrics
Determinants of Prognosis in PAH
2015 ESC/ERS Risk Evaluation
SPAHR Risk Stratification
French Registry Low-Risk Criteria
COMPERA Registry Risk Stratification
Summary of 3 European Studies
French Registry BNP Subset Analysis
ESC/ERS 2015 Treatment Algorithm for PAH
The Rationale for Combination Therapy
The Ambrisentan and Tadalafil in Patients With PAH (AMBITION) Trial
Initial Combination Therapy for WHO FC III
3 Month Follow-Up on ERA/PDE5i
Treatment Options
GRIPHON Treatment Effect by Subgroup
Back to the Case
Revisiting the Decision to Stay the Course…
Take-Home Points
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
Abbreviations (cont)